Therefore, activation of the β-catenin and PPARγ pathways in VAT-cDCs may serve not only to restrain obesity-induced inflammation, but also to promote pathogen persistence and tumor growth. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.